在肺腺癌中,FoxA1/2-依赖的表观基因组重编程驱动了血统切换
Katherine Gillis1, Walter A Orellana1, Emily Wilson1
1Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA; Department of Oncological Sciences, University of Utah, Salt Lake City, UT, USA.
Developmental cell
|November 8, 2024
概括
癌细胞可以改变身份,影响瘤生长和治疗. 福克斯A1/2蛋白重新编程表观遗传场景,驱使肺癌细胞在失去NKX2-1后采取胃身份,NKX2-1是一个关键的肺细胞调节器.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 血统可塑性,或癌细胞身份变化,对于瘤进展和治疗反应至关重要.
- 在KRAS驱动的肺腺癌 (LUAD) 中,NKX2-1的丧失促进了瘤的生长,并诱导了由FoxA1/2.2调解的肺到胃血统切换.
研究的目的:
- 阐明FoxA1/2在NKX2-1损失后在肺癌细胞中激活潜伏的胃身份的机制.
- 调查FoxA1/2在LUAD中的表观遗传重编程和3D染色质重塑中的作用.
主要方法:
- 使用KRAS驱动的LUAD与NKX2-1损失的小鼠模型.
- 分析了表观遗传修饰,包括DNA脱甲基和H3K27ac沉积.
- 研究了十-十一转位 (TET) 2/3招募和3D染色体相互作用.
- 研究了瘤信号在表观遗传重编程中的作用.
主要成果:
- 福克斯A1/2促进TET2/3招募,DNA脱甲基化,H3K27ac沉积和3D染色体相互作用,以重编程胃特异性基因.
- 在人类内皮发育和瘤中,FoxA1/2-介导的DNA甲基化变化被保留.
- 对于FOXA1/2驱动的表观遗传重编程的特定方面,癌原信号是必要的.
结论:
- 福克斯A1/2在NKX2-1阴性LUAD的表观遗传和3D染色质景观的重新连接中发挥着至关重要的作用.
- 这种重编程驱使癌细胞系转向胃的身份.
- 这些发现突出了带有血统可塑性的LUAD的潜在治疗点.
更多相关视频
相关概念视频
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Forced Transdifferentiation
1.9K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
Artificial...
1.9K
Chromatin Modification in iPS Cells
1.6K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.6K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K


